DEVELOPMENT AND EVALUATION OF GEL CONTAINING PHOSPHATIDYLCHOLINE COMPLEXES OF ARBUTIN AND CURCUMIN AS SKIN WHITENING AGENT Authors: Patel RK And Jadeja MB*
ABSTRACT
Arbutin and curcumin are widely used for the treatment of hyperpigmentation. A very
hydrophilic drug (arbutin) is unable to penetrate the skin, while a very lipophilic drug
(curcumin) has the propensity to remain in the layers of the stratum corneum; so, there is
need for enhancement of penetration for both drugs. Gel containing phosphatidyl complexes
of drugs have emerged as one of the most interesting topical delivery systems as it has dual
control release systems i.e., gel and complexes. One side the topical applications of the drugs
offers the potential advantages of delivering the drug directly to the site of action and
secondly delivering the drug for extended period of time at the affected site. The major
objective behind this formulation was enhancing the topical delivery of both drugs by
formulating gel containing phosphatidylcholine complexes. Optimized formulation of
complexes of both drugs incorporated into gel base and evaluated for visual examination,
spreadability, pH, and viscosity. The prepared gel was light yellowish in color and showed
good homogeneity with the absence of lumps and syneresis. Spreadability, pH, and viscosity
of prepared gel was found 5.86 ± 0.057, 5.53 ± 0.115, and 17535.66 ± 5.859, respectively.
The in-vitro drug release was found 81.05 ± 2.62 and 77.67 ± 3.60 after 300 minutes for
arbutin and curcumin, respectively from prepared gel. Recovery of arbutin and curcumin
from the prepared gels was 99.66% and 98.48%, respectively. No change in color, odor, and homogeneity, as well as a negligible change in pH and net content of the prepared
formulation, was observed during and completion of stability testing.
Keywords: Hyperpigmentation, Arbutin, Curcumin, Phospholipid complexes, Topical
gel Publication date: 01/10/2021 https://ijbpas.com/pdf/2021/October/MS_IJBPAS_2021_OCT_SPCL_1032.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2021/10.10.1032